New York, NY -- (SBWIRE) -- 12/20/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Avanir Pharmaceuticals Inc (NASDAQ:AVNR), DCT Industrial Trust Inc (NYSE:DCT), OCZ Technology Group Inc (NASDAQ:OCZ), Alimera Sciences Inc (NASDAQ: ALIM),
Avanir Pharmaceuticals Inc (NASDAQ:AVNR) showed a volume of 4.41 million shares by the end of last trade whereas the average volume of the stock remained 2.61 million shares. The stock opened the session at $2.65 but then moved to $2.87. At that price, the stock showed a positive performance of 8.30%. AVANIR Pharmaceuticals, Inc. (AVANIR) is a pharmaceutical company focused on developing and commercializing therapeutic products for the treatment of central nervous system disorders. The Company focuses on products for the central nervous system. It also has a number of partnered programs in other therapeutic areas. Its docosanol 10% cream, sold in the United States and Canada as Abreva by its marketing partner GlaxoSmithKline Consumer Healthcare,
Will AVNR Continue To Move Higher? Find Out Here
DCT Industrial Trust Inc (NYSE:DCT) opened the session at $7.05 and closed the session at $7.11. The stock showed a negative performance of -1.11% in previous trading session. Traded with volume of 4.36 million shares in the prior session and the average volume of the stock remained 4.27 million shares. DCT Industrial Trust Inc. (DCT) is an industrial real estate company that owns, operates and develops bulk distribution and light industrial properties in distribution markets in the United States and Mexico. The Company is structured as an umbrella partnership real estate investment trust (REIT), under which substantially all of its business is, and will be, conducted through a majority-owned and controlled subsidiary, DCT Industrial Operating Partnership LP (the operating partnership), a Delaware limited partnership, for which DCT Industrial Trust Inc.
Has DCT Found The Bottom And Ready To Gain Momentum? Find Out Here
OCZ Technology Group Inc (NASDAQ:OCZ) opened the session at $0.06 and closed the session at $0.0580. The stock showed a negative performance of -5.07% in previous trading session. Traded with volume of 4.31 million shares in the prior session and the average volume of the stock remained 7.03 million shares. The beta of the stock remained 26.12. OCZ Technology Group, Inc. (OCZ) designs, manufactures, and distributes solid-state drives (SSDs) and computer components. OCZ designs and manufactures SSDs in a variety of form factors and interfaces including Serial advanced technology attachment (SATA), serial-attached small computer system interface (SAS), peripheral component interconnect express (PCIe), as well as the development of flash management software, caching and virtualization software. The Company is also a provider of flash controller silicon and firmware for SSDs.
Why Should Investors Buy OCZ After the Recent Fall? Just Go Here and Find Out
Alimera Sciences Inc (NASDAQ: ALIM) the stock advanced 62.75% and finished the session at $4.15. Traded with volume of 4.31 million shares in the prior session and the average volume of the stock remained 89,934.00 shares. The beta of the stock remained 1.44. Alimera Sciences, Inc.is a biopharmaceutical company that develops and commercializes prescription ophthalmic pharmaceuticals. The Company advanced product candidate, ILUVIEN, is a tiny, cylindrical polyimide tube that contains 190 g of fluocinolone acetonide (FAc), a corticosteroid with a history of treating ocular diseases. ILUVIEN is in development for the treatment of DME, a disease of the retina that affects individuals with diabetes and can lead to severe vision loss and blindness. The Company is based in Alpharetta, Georgia, United States.
Will ALIM Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)